Sector: Pharmaceuticals & Biotechnology

Mid Cap

Alivus Life Sciences Share Price

ALIVUS

₹1,145.90

15.80(1.40%)

9th Jul 2026 | 3:28 PM

NSE : ALIVUS

Open Free Demat Account

Alivus Life Sciences Performance

Price Movement

₹1145.90

₹1130.10

₹1171.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1145.90

₹819.00

₹1193.90

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,171.00

Low₹1,130.10

Open at₹1,135.30

Prev Close₹1,130.10

Volumes50.91 K

Avg Price₹1,152.73

Lower Circuit₹904.10

Upper Circuit₹1,356.10

Historical Performance

3M High₹1,192.00

3M Low₹994.30

1 Yr High₹1,192.00

1 Yr Low₹819.00

3 Yr High₹1,335.10

3 Yr Low₹564.30

5 Yr High₹1,335.10

5 Yr Low₹370.00

Summary

As of 09-07-2026 17:16, Alivus Life Sciences Ltd. share price today is ₹0, with a change of ₹-1130.10 (-100.00%) from the previous close of ₹1130.1. The stock opened at ₹1135.3 and traded between ₹1130.1 and ₹1171, with a total traded volume of 50907 shares. The company has a market capitalization of ₹14050 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1193.9 and ₹819, respectively.

Alivus Life Sciences Ltd. valuation metrics include a P/E ratio of 24.9, and book value of ₹4.20. Profitability indicators show ROE of 16.94% along with a dividend yield of 0.4%. Alivus Life Sciences Ltd. has reported revenue of ₹2551.83 Cr and net profit of ₹564.48 Cr.

Alivus Life Sciences Ltd. technical indicators include Day RSI at 63.54, Day MFI at 79.84, Day ADX at 23.32. Additional indicators include Commodity Channel Index (CCI) at 83.2 and Williams %R at -32.24. Momentum indicators show Day MACD at 27.48, Day MACD Signal Line at 21.02, DayATR at 37.75. Rate of Change indicators for Alivus Life Sciences Ltd. include ROC125 at 24.89 and ROC21 at 10.87.

Exponential moving averages include EMA5 at ₹1145.9, EMA10 at ₹1131.9, EMA12 at ₹1126.1, EMA20 at ₹1108, EMA26 at ₹1098.6, EMA50 at ₹1072.3, EMA100 at ₹1034.4, EMA200 at ₹1003.5. Simple moving averages include SMA5 at ₹1149.7, SMA10 at ₹1136.8, SMA20 at ₹1092.8, SMA30 at ₹1077.5, SMA50 at ₹1073.4, SMA100 at ₹1018.3, SMA150 at ₹978.6, SMA200 at ₹966.1.

Support levels for Alivus Life Sciences are placed at First Support ₹1130.20, Second Support ₹1115.70, Third Support ₹1095.80. Resistance levels are seen at First Resistance ₹1164.60, Second Resistance ₹1184.50, Third Resistance ₹1199.00. Alivus Life Sciences Ltd. shareholding pattern shows promoter holding at 74.87%, FII holding at 5.3%, DII holding at 0%, public holding at 12.55%.

Alivus Life Sciences Fundamentals

Market Cap

High in industry

14,050 Cr.

PE Ratio (TTM)

Above industry Median

24.90

Dividend Yield

Below industry Median

0.40

Net Profit TTM

16.2% incr over last year

564.48

Net Profit Growth

16.2% incr over last year

564.48

PEG Ratio

Above industry Median

1.50

ROE

2% decr over last year

16.94

Operating Revenue TTM

2,551.83

Operating Revenue Growth

6.9% incr over last year

Book Value

Above industry Median

4.20

MFI

MFI Overbought

79.84

RSI

RSI is mid-range

63.54

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

4.20

Alivus Life Sciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	689.12	672.89	587.98	601.85	649.54
Operating Expense	474.59	441.62	408.81	429.54	451.11
Operating Profit	214.53	231.27	179.17	172.31	198.43
Depreciation	20.20	19.66	18.44	17.06	15.97
Interest	1.31	1.49	1.32	1.25	1.26
Tax	53.14	48.13	44.11	41.45	49.42
Net Profit	162.66	150.26	130.03	121.54	141.87

Alivus Life Sciences Technicals

Alivus Life Sciences Ltd. EMA & SMA

₹1145.90

-4.60 (-0.40%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1145.9

Day EMA10 ₹1131.9

Day EMA12 ₹1126.1

Day EMA20 ₹1108

Day EMA26 ₹1098.6

Day EMA50 ₹1072.3

Day EMA100 ₹1034.4

Day EMA200 ₹1003.5

Alivus Life Sciences Support and Resistance

Resistance

First Resistance₹1164.60

Second Resistance₹1184.50

Third Resistance₹1199.00

Support

First Support₹1130.20

Second Support₹1115.70

Third Support₹1095.80

Technical Indicators

Day RSI63.54

Day MFI79.84

Day ADX23.32

Day Commodity Channel Index83.20

William-32.24

Day MACD27.48

Day MACD Signal Line21.02

Day ATR37.75

Day ROC12524.89

Day ROC2110.87

Alivus Life Sciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	75	75	74.9	74.9	74.9	74.9
FII	6.7	6.6	6.4	6.8	5.1	5.3
DII	4.9	5.2	5.6	5.5	7.1	7.3
Public	13.4	13.2	13	12.8	12.9	12.6

Alivus Life Sciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	16.02 K	34.93 K	45.88%
Week	76.27 K	1.27 L	60.06%
1 Month	71.27 K	1.31 L	54.24%
6 Month	57.39 K	1.03 L	55.48%

Alivus Life Sciences SWOT Analysis

Strengths22

Weakness8

Opportunity6

Threats3

Companies with no Debt

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 3 quarters

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Alivus Life Sciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Sep, 2025	5	FINAL	01 Sep, 2025	Equity Share
17 Oct, 2023	22.5	INTERIM	17 Oct, 2023	Equity Share
24 Mar, 2023	21	INTERIM	24 Mar, 2023	Equity Share
15 Sep, 2022	10.5	FINAL		Equity Share
22 Nov, 2021	10.5	INTERIM	23 Nov, 2021	Equity Share

Alivus Life Sciences Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,027.20	₹807	₹1,418.10	₹1,625	₹4,508	₹660
% Change	2.41%	0.84%	0.59%	0.81%	-0.69%	1.95%
Revenue TTM (₹ Cr)	₹1,403.18	₹642.26	₹649.50	₹1,421.59	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	₹172.89	₹115.38	₹-73.80	₹257.90	₹255.19
PE TTM	65.70	53.00	54.20	-252.70	41.10	40.10
1 Year Return	87.27	36.75	136.79	-18.59	-14.34	14.03
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 992.00

+0.93%

BLUEJET

Blue Jet Healthcare Ltd

₹ 575.75

+2.32%

CONCORDBIO

Concord Biotech Ltd.

₹ 1311.20

+4.08%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 704.00

+2.59%

SUPRIYA

Supriya Lifescience Ltd.

₹ 876.50

+1.72%

COHANCE

Cohance Lifesciences Ltd.

₹ 441.00

+2.37%

ERIS

Eris Lifesciences Ltd.

₹ 1430.00

+0.99%

SYNGENE

Syngene International Ltd.

₹ 415.85

+1.03%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 816.00

+0.58%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 278.05

+2.99%

STAR

Strides Pharma Science Ltd.

₹ 1072.00

-0.81%

FDC

FDC Ltd.

₹ 431.70

+1.96%

SHILPAMED

Shilpa Medicare Ltd.

₹ 624.80

+4.95%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 972.00

+0.13%

NATCOPHARM

Natco Pharma Ltd.

₹ 961.55

-0.49%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2626.00

+3.86%

MARKSANS

Marksans Pharma Ltd.

₹ 278.80

+5.83%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1050.00

+4.76%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 526.90

+2.72%

SANOFI

Sanofi India Ltd.

₹ 3349.00

-0.96%

PGHL

Procter & Gamble Health Ltd.

₹ 6600.00

+5.39%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 590.00

+4.71%

FAQ's on ALIVUS

What is the current share price of Alivus Life Sciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Alivus Life Sciences Ltd. is ₹ 1145.9 on the NSE and ₹ 1144.8 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Alivus Life Sciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Alivus Life Sciences Ltd. is approximately ₹ 14050 Cr.

What are the PE and PB ratios for Alivus Life Sciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Alivus Life Sciences Ltd. is 24.9, and the Price-to-Book (PB) ratio is 4.2.

What is the 52-Week High and Low for Alivus Life Sciences Ltd.?

Over the past 52 weeks, the highest price reached by Alivus Life Sciences Ltd. shares was ₹ 1192, and the lowest price was ₹ 819.

What is the current dividend yield for Alivus Life Sciences Ltd.?

As of 6 June 2025, the dividend yield for Alivus Life Sciences Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Alivus Life Sciences Ltd.?

Significant shareholdings in Alivus Life Sciences Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Alivus Life Sciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Alivus Life Sciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Alivus Life Sciences Ltd.?

Alivus Life Sciences Ltd. last declared a FINAL dividend of ₹ 5 per share for the financial period ending 2025. The record date was set as 2025-09-01, and the payment was/is scheduled around 2025-09-01. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy